BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29595810)

  • 1. Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein.
    Liu SJ; Wang JY; Peng SH; Li T; Ning XH; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
    Genet Med; 2018 Oct; 20(10):1266-1273. PubMed ID: 29595810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algorithmic assessment of missense mutation severity in the Von-Hippel Lindau protein.
    Fields FR; Suresh N; Hiller M; Freed SD; Haldar K; Lee SW
    PLoS One; 2020; 15(11):e0234100. PubMed ID: 33151962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VHL mutations linked to type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL.
    Knauth K; Cartwright E; Freund S; Bycroft M; Buchberger A
    J Biol Chem; 2009 Apr; 284(16):10514-22. PubMed ID: 19228690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.
    Gossage L; Pires DE; Olivera-Nappa Á; Asenjo J; Bycroft M; Blundell TL; Eisen T
    Hum Mol Genet; 2014 Nov; 23(22):5976-88. PubMed ID: 24969085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.
    Yoshida M; Ashida S; Kondo K; Kobayashi K; Kanno H; Shinohara N; Shitara N; Kishida T; Kawakami S; Baba M; Yamamoto I; Hosaka M; Shuin T; Yao M
    Jpn J Cancer Res; 2000 Feb; 91(2):204-12. PubMed ID: 10761708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.
    Mougel G; Mohamed A; Burnichon N; Giraud S; Pigny P; Bressac-de Paillerets B; Mirebeau-Prunier D; Buffet A; Savagner F; Romanet P; Arlot Y; Gardie B; Gimenez-Roqueplo AP; Beroud C; Richard S; Barlier A
    J Med Genet; 2024 Mar; 61(4):378-384. PubMed ID: 37979962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
    Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
    Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the science: an update on renal cell carcinoma.
    Jonasch E; Futreal PA; Davis IJ; Bailey ST; Kim WY; Brugarolas J; Giaccia AJ; Kurban G; Pause A; Frydman J; Zurita AJ; Rini BI; Sharma P; Atkins MB; Walker CL; Rathmell WK
    Mol Cancer Res; 2012 Jul; 10(7):859-80. PubMed ID: 22638109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine tumors in French VHL mutation carriers: a multicentric retrospective study.
    Muller M; Hammel P; Couvelard A; Védie AL; Cros J; Burnichon N; Hercent A; Sauvanet A; Richard S; de Mestier L
    J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38706378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Most Common
    Buart S; Terry S; Diop MK; Dessen P; Couvé S; Abdou A; Adam J; Thiery J; Savagner P; Chouaib S
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease.
    Larcher A; Belladelli F; Cei F; Re C; Rowe I; Montorsi F; Capitanio U; Salonia A
    Nat Rev Urol; 2024 May; ():. PubMed ID: 38719914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review.
    Ganeshan D; Menias CO; Pickhardt PJ; Sandrasegaran K; Lubner MG; Ramalingam P; Bhalla S
    Radiographics; 2018; 38(3):849-866. PubMed ID: 29601266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genotype-Phenotype Association of Von Hipple Lindau Disease Based on Mutation Locations: A Retrospective Study of 577 Cases in a Chinese Population.
    Qiu J; Zhang K; Ma K; Zhou J; Gong Y; Cai L; Gong K
    Front Genet; 2020; 11():532588. PubMed ID: 33362845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.
    Ma K; Hong B; Zhou J; Gong Y; Wang J; Liu S; Peng X; Zhou B; Zhang J; Xie H; Zhang K; Li L; Cai D; Wang Z; Cai L; Gong K
    Front Oncol; 2019; 9():1122. PubMed ID: 31737565
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study.
    Xie H; Ma K; Zhang J; Hong B; Zhou J; Li L; Zhang K; Gong K; Cai L
    J Med Genet; 2020 Nov; 57(11):744-751. PubMed ID: 32303605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors.
    Minervini G; Quaglia F; Tabaro F; Tosatto SCE
    PLoS Comput Biol; 2019 Apr; 15(4):e1006478. PubMed ID: 30943211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between vasectomy and risk of prostate cancer: a meta-analysis.
    Xu Y; Li L; Yang W; Zhang K; Ma K; Xie H; Zhou J; Cai L; Gong Y; Zhang Z; Gong K
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):962-975. PubMed ID: 33927357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
    Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
    J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
    Peng X; Chen J; Wang J; Peng S; Liu S; Ma K; Zhou J; Hong B; Zhou B; Zhang J; Cai L; Gong K
    J Med Genet; 2019 Jun; 56(6):380-387. PubMed ID: 30745424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma.
    Richter S; Bechmann N
    J Endocr Soc; 2024 Mar; 8(5):bvae038. PubMed ID: 38481600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.